Stock screener

CYTK

Conviction 80HealthcareScan · Mon, Jul 20, 2026
CYTK$79.10-1.35%
ResistanceSupportVol 14Insider sellCongress buyCongress sell
63 bars
Gilbert Cisneros
3
Vol MA14 1.92M
Apr 20May 6May 26Jun 11Jul 1Jul 20
CYTOKINETICS INCPHARMACEUTICAL PREPARATIONSwww.cytokinetics.com ↗
Price79.10
Change-1.35%
Gap+0.79%
Rel volume0.91×
Avg volume2.37M
Avg $ vol196.92M
SMA 2083.05
SMA 5077.82
SMA 20066.97
Price vs 50+1.64%
Price vs 200+18.10%
MA stackbullish
50/200 cross—
Supertrendup · 77.56
RSI (14)46
MACD hist-1.01
MACD crossbear · 5d
Stoch %K / %D8 / 11
ADX (14)27
+DI / −DI19 / 17
RSI divergence—
MACD divergence—
ATR %+3.99%
ADR %3.59%
52w high87.26
52w low33.23
From 52w high-9.35%
Above 52w low+138.04%
New 52w highNo
SqueezeOff
Bollinger width12.47%
%B0.12
Donchian pos8.27%
Donchian high88.31
Donchian low78.27
AVWAP (52w high)83.92
vs AVWAP high-5.74%
AVWAP (52w low)64.08
vs AVWAP low+23.43%
OBV trendFlat
Chaikin MF (20)-0.00
Today vs 20d0.91×
Avg vol (14d)1.92M
Avg vol (20d)2.37M
Avg $ vol (20d)196.92M
Market cap9.84B
RS 3m (vs SPY)+16.63%
RS 6m (vs SPY)+16.45%
RS line new highNo
Trend template8/8
Technical rank74.0
1 week-3.82%
1 month+1.27%
3 months+18.57%
6 months+24.69%
1 year+103.39%
YTD+28.14%
P/E-12.54
P/B-11.91
P/S111.80
P/FCF-18.40
EPS-6.54
Div yield—
ROE94.97%
ROA-61.64%
Debt/Eq-0.35
Current4.21
EV/EBITDA-16.62
Gross margin—
Net margin-891.60%
Rev growth376.56%
EPS growth-33.15%
Price target107.21
Target upside35.54%
Analyst ratingBuy
Institutional127.39%
Ent. value10B
Revenue19.36M
Net income-206.03M
Gross profit—
Free cash flow-534.82M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out124.43M
Employees673
ListedThu, Apr 29, 2004
Free float120.88M
Float %97.3%
Short interest17.57M
Days to cover5.3d
Short volume65.1%
Squeeze score71 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$1.67 vs −$1.67
Last surprise0.0% beat
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank74.0 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance88.12
Support68.40
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CYTK · 4 recent

All disclosures →
MemberSideAmount
Gilbert Cisneros
Gilbert Cisneros
house · D · CA · traded 2026-06-30
Buy$1K–$15K
Gilbert Cisneros
Gilbert Cisneros
house · CA · traded 2025-10-09
Buy$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-17
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · R · MI · traded 2025-06-11
Buy$1K–$15K

Insider activity

SEC Form 4 transactions in CYTK · 7 buys · 3 sells

InsiderSideShares
Daly James M
Director · Common Stock · 2026-07-15
Grant151
Harrington Robert Arthur
Director · Common Stock · 2026-07-15
Grant151
HENDERSON JOHN T
Director · Common Stock · 2026-07-15
Grant272
Kaye Edward M. MD
Director · Common Stock · 2026-07-15
Grant151
WIERENGA WENDELL
Director · Common Stock · 2026-07-15
Grant75
Wysenski Nancy
Director · Common Stock · 2026-07-15
Grant75
Malik Fady Ibraham
EVP Research & Development · Common Stock · 2026-07-07
Exercise3.5K
Malik Fady Ibraham
EVP Research & Development · Common Stock · 2026-07-07
Sell3.5K
Malik Fady Ibraham
EVP Research & Development · Non-Qualified Stock Option (Right to Buy) · 2026-07-07
Exercise3.5K
Lee Sung
EVP, Chief Financial Officer · Incentive Stock Option (Right to Buy) · 2026-06-29
Exercise188

SEC filings

EDGAR filings in CYTK · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.